MedsAware: Deprescribing Action Week

MedsAware Deprescribing Action Week raises awareness around polypharmacy and deprescribing. In 2025, MedsAware turns its attention towards sustainability highlighting the benefits of deprescribing that can be felt all around us – for patient and planet.

MedsAware 2025 campaign resources →


On this page:


Empowering safe and sustainable use of medicines

Medicines can have important benefits in curing and preventing diseases and improving symptoms. However, the potential benefits and harms of medicines can change over time as a person ages, acquires new medical conditions, takes new medicines and changes their care goals. Therefore, medicines should be regularly reviewed to make sure that they are still of benefit, and not causing any harms. 

Medicines can also impact the world around us.

Globally health systems account for 4.4% of all greenhouse gas emissions and sadly for us in Australia this number sits even higher at 7%. Hospitals and medicines alone account for two thirds of the carbon footprint associated with health care in Australia.[1]

Reference: Kouladjian O’Donnell L, 2024
 

Building ‘planetary consciousness’ in healthcare practice, policy, research, and education is critical; we cannot ignore the fact that climate change is the biggest health threat of this century. Reducing the impact of medicines on the natural environment is a fundamental principle of Australia’s National Medicines Policy.

[1]The carbon footprint of Australian health care’, Malik, Arunima et al. The Lancet Planetary Health, Volume 2, Issue 1, e27 - e35


How a conversation around your medicines can make you - and the planet - healthier

‘Deprescribing’ describes the process of stopping medicines that are no longer required, or for which the risk of harm outweighs the benefits in the individual.*

Deprescribing also affords us the opportunity to not only improve medicines safety and patient care directly, but to contribute to a more sustainable and healthier planet.

Australians should be empowered to think safely and sustainably about their medicines.

By taking small steps, beginning with a simple conversation with your doctor or pharmacist, we can all help reduce the environmental impact of medicines.

*Medicines should never be stopped without talking to a doctor or pharmacist.

  • MedsAware Deprescribing Action Week is about driving conversations around discontinuing medicines that are no longer required, or for which the risk of harm outweighs the benefits. 
  • MedsAware seeks to raise awareness around ‘polypharmacy’ and ‘deprescribing’, empowering Australians and their care teams to manage every medicines regimen ensuring it is current, effective and safe. 
  • #MedsAware supports and raises awareness of Australia’s 10th National Health Priority Area, Quality Use of Medicines and Medicines Safety.
     

  • Polypharmacy refers to the use of multiple medicines, usually defined as the use of five or more regular medicines. 

  • Australian research indicates nine in 10 Australians in aged care take at least five regular medicines every day, and 65% take more than 10 ('hyperpolypharmacy'). 

  • Polypharmacy and hyperpolypharmacy are associated with increased risk of side effects and other medicine related harms like falls and hospitalisation

  • 250,000 Australians are admitted to hospital each year due to medication-related issues, many of which are preventable; we need to break this cycle.1

  • Deprescribing describes the process of discontinuing medicines that are no longer required, or for which the risk of harm outweighs the benefits.

  • Think of deprescribing as spring cleaning for your medicine cabinet. Just like how you tidy up your house and get rid of objects that are causing clutter without being useful, deprescribing tidies up your medication list to keep only the ones that are truly required. 

  • Deprescribing is safe when planned and supervised by a healthcare professional. 

  • Deprescribing minimises the risk of withdrawal effects through careful monitoring and gradual tapering of medicines. 

  • Deprescribing empowers the care team and the patient through safer, shared decision-making.


 

MedsAware 2025: Four steps toward sustainability

To ensure Australians can use medicines safely and sustainably, we urge policymakers to take action:

  • Make Sustainability a Priority in Procurement – Update government purchasing practices to consider the carbon footprint of medicines, fluids, and medical devices, ensuring greener choices in the supply chain.
  • Incorporate Carbon Costs in Medicine Assessments – Align with international best practices by factoring sustainability into medicine evaluations, as recommended in the Health Technology Assessment (HTA) Policy and Methods Review.
  • Update National Guidelines for Smarter Prescribing – Ensure resources like Therapeutic Guidelines reflect evidence-based decision-making that weighs sustainability alongside safety, quality, and efficacy.
  • Increase Transparency in Pharmaceutical Emissions – Collaborate with the industry to improve data-sharing on carbon costs, empowering clinicians to make informed choices that support Australia’s National Health and Climate Strategy.

Let’s take action now to build a healthier, more sustainable future for all Australians.


Some questions to ask about your medicines 

What medications do I need to keep taking, and why? 

Have any medications been added, stopped or changed, and why? 

How will I know if my medication is working and what side effects do I watch for? 

How will this medicine help me? 

How do I take this medicine and for how long? 

What are the risks of taking this medicine? 

What else can I do? 

I don’t like taking this medicine. I’m worried it’s giving me side effects, or I don’t think it is working. Could you please review it? 

I’m not sure why I take this medicine. Could we talk about this? 

I would like you to please review if I still need this medicine. Could I possibly stop taking this medicine?

Sources:  
https://www.choosingwisely.org.au/assets/NPSMW2464_GMBH_5-QuestionsAboutYourMedicines.pdf
https://www.ismp-canada.org/download/MedRec/5questions/MedSafetyPoster-CaDeN-EN.pdf 
https://onlinelibrary.wiley.com/doi/10.1111/bcpt.13938
 

News and Events

Want to learn more about deprescribing and sustainability? Come along to our FREE webinars:

MedsAware Deprescribing Action Week 2025: Empowering safe and sustainable use of medicines

Webinar: Empowering safe and sustainable use of medicines

This webinar will examine the link between deprescribing and the environmental impact of medicines, highlighting the benefits of deprescribing – for people and the planet.

Register →

MedsAware Deprescribing Action Week 2025: Reducing medication waste in hospitals

Webinar: Reducing medication waste in hospitals

Medication waste in hospitals and healthcare systems is a significant source of environmental and financial waste. This webinar will overview the impact of medication use on the environment and provide practical insights into multidisciplinary approaches that can reduce medication waste.

Register →


"I am proud to be supporting the MedsAware 2025 Deprescribing Action Week.
 

Deprescribing is a “win win” action – reduction in medication misadventure risk and financial cost for patients, and reduction in environmental impact of the manufacture, use and disposal of medicines. I am delighted that the MedsAware 2025 campaign are bringing the benefits of deprescribing for people and the planet to the forefront for consumers and healthcare professionals.
 

This type of campaign has the potential to drive simple conversations and create change, one small step at a time. I encourage everyone to take part in this year’s MedsAware to be empowered to use medicines safely and sustainably."

Grace Wong FAdPha
MedsAware 2025 Campaign Ambassador
Founding Member of AdPha’s Climate and Health Specialty Practice Group, Founder of Pharmacists for the Environment Australia



 

‘The world’s first published use of “deprescribing” was in our flagship Journal of Pharmacy Practice and Research (JPPR) 20 years ago, in ‘Deprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications’.

‘As medicines experts, pharmacists are best placed to detect and prevent inappropriate use of high-risk medicines that can benefit both the health of patients and the environment around us.

'This year MedsAware Week seeks to empower Australians and their carers, family and friends, together with pharmacists, doctors and other care team members, to think safely and sustainably about medicine use.

‘We’re proud to lead the MedsAware message and work with our partners to embed deprescribing as a central principle of safe, sustainable health care.’

— Advanced Pharmacy Australia (AdPha) President, Tom Simpson

'Deprescribing is an essential part of achieving quality use of medicines, ensuring that each individual is taking the right medicines at the right time. It can have broad reaching benefits for individuals including reducing pill burden, medication costs and risk of side effects and improving quality of life. This MedsAware week, we are also discussing a future where our health and the health of our planet go hand in hand.'

— Emily Reeve, ADeN Chair

'Deprescribing is a powerful tool in creating a sustainable healthcare system, through the longstanding policy of FIP – rational use of medicines. By addressing polypharmacy, pharmacists play a key role in reducing waste, lowering environmental impact, and enhancing patient safety. Building awareness for deprescribing is vital to ensuring that healthcare practices remain both effective and sustainable.'

— Paul Sinclair AM, FIP president

'We are all aware of the health harms caused by over-prescribing, with the risks of interaction of multiple medications increasing as our patients age and new comorbidities emerge. Sometimes our medications can even cause the very conditions we are trying to prevent. Medications also carry a carbon footprint, contributing about 20% of the emissions of Australian healthcare.

Deprescribing unnecessary medications can improve our patients' health and by avoiding the carbon emissions, have positive impacts on our planet's health too.

As global heating becomes increasingly alarming, we as health professionals have a responsibility to do what we can, and deprescribing is a simple effective way we can all make a contribution.'

— Distinguished Laureate Professor Nicholas J. Talley AC

'The RACGP supports reducing patients’ use of unnecessary or potentially harmful medications.

'As a person’s health changes, so do their medication needs. At the same time, we know there are people missing out on preventive medicines that could save lives.

'It’s important to see your regular GP who knows you and your medical history to review what medication you’re taking and see if any can be reduced or stopped. Its critical that you don’t stop a medicine without talking to your doctor or pharmacist first. 

'Getting the right mix of medicines for people with multiple long-term conditions is complex, and people who see different specialists often end up with a big collection of medicines. Specialist GPs are trained in patient-centred care and as generalists we support our patients to make sense of it all, and what is best for them.'

— Dr Michael WrightRACGP President

'EAHP proudly supports MedsAware in empowering patients through deprescribing."

'Hospital pharmacists work in collaboration with patients and healthcare professionals to ensure medications can be discontinued safely and effectively when they no longer provide benefit. By reducing unnecessary medication use, we not only enhance patient health by preventing side effects, drug interactions, and nonadherence, but we also contribute to a more sustainable future. Responsible medication use reduces pharmaceutical waste, minimises environmental impact, and optimises healthcare resources—creating a healthier world for all.'

— Nenad Miljkovic, EAHP President

‘Throughout their degree, pharmacy students are taught that in many cases medicines or a combination of medicines are not appropriate for a patient. What may have been necessary to treat a patient in the past, may no longer be in their best interest. Appreciation for deprescribing is ingrained in the next generation of pharmacists.’

— Sebastian Harper, NAPSA National President

'Deprescribing not only prioritises patient safety and well-being but also reduces pharmaceutical waste, environmental pollution, and greenhouse gas emissions. By minimising unnecessary medication use and ensuring appropriate medication stewardship, we can lower the environmental burden of drug production, distribution, and disposal while simultaneously optimising patient outcomes. This dual-purpose approach supports both human health and planetary health, fostering a more sustainable healthcare system as a part of best practices in patient care.'

— Hayley Blackburn, Co-Founder, Rx for Climate

'Raising awareness about deprescribing is vital for enhancing patient safety and promoting environmental sustainability. Deprescribing reduces the use of unnecessary medicines, thereby decreasing potential harm to patients and lessening the environmental impact of pharmaceutical waste. The Council of Australian Therapeutic Advisory Groups (CATAG) supports deprescribing through Medicines Stewardship. By providing resources and educational tools, CATAG helps healthcare professionals implement deprescribing practices, ultimately improving patient safety and reducing the environmental impact of pharmaceuticals.'

— Anita Shutt, Chair of CATAG

'We are all aware of the health harms caused by over-prescribing, with the risks of interaction of multiple medications increasing as our patients age and new comorbidities emerge. Sometimes our medications can even cause the very conditions we are trying to prevent. Medications also carry a carbon footprint, contributing about 20% of the emissions of Australian healthcare.

Deprescribing unnecessary medications can improve our patients' health and by avoiding the carbon emissions, have positive impacts on our planet's health too.

As global heating becomes increasingly alarming, we as health professionals have a responsibility to do what we can, and deprescribing is a simple effective way we can all make a contribution.'

— Distinguished Laureate Professor Nicholas J. Talley AC


Our supporters

Are you interested in becoming a MedsAware 2025 supporter? Submit your expression of interest today!

Become a supporter →



Founding partner: Australian Deprescribing Network (ADeN)

The Australian Deprescribing Network (ADeN) involves clinicians, academic researchers, policy makers, students and consumers working together to develop the evidence-base, clinical guidance and knowledge translation to facilitate deprescribing of medicines that are no longer providing benefit or are causing harm. ADeN aims to promote research, awareness, practice and policy for the safe and appropriate use of medicines for all Australians.

ADeN are a joint founding partner of MedsAware: Deprescribing Action Week.

Visit their website to:

  • Learn more about deprescribing
  • Find resources to support deprescribing in practice including guidelines, communication tools and resources for the public
  • Learn about their upcoming events
  • Sign up to their email list to hear about upcoming opportunities, news, events and more!

Follow ADeN on X: @DeprescribeAU
 

Proudly supported by:

European Association of Hospital Pharmacists (EAHP) International Pharmaceutical Federation (FIP) Royal Australian College of General Practitioners (RACGP)
Registry of Senior Australians (ROSA) Research Centre Council of Australian Therapeutic Advisory Groups (CATAG)

Rx for Climate

Pharmacists for the Environment Australia National Asthma Council Australia National Australian Pharmacy Students' Association (NAPSA)

Australian Journal of Pharmacy

Official Media Partner

Doctors for the Environment Australia Australian Medican Association
Guild of Healthcare Pharmacists UK

Australian Deprescribing Network

Australian Deprescribing Network (ADeN)

The Australian Deprescribing Network (ADeN) involves clinicians, academic researchers, policy makers, students and consumers working together to develop the evidence-base, clinical guidance and knowledge translation to facilitate deprescribing of medicines that are no longer providing benefit or are causing harm. ADeN aims to promote research, awareness, practice and policy for the safe and appropriate use of medicines for all Australians.

Visit their website to:

  • Learn more about deprescribing             
  • Find resources to support deprescribing in practice including guidelines, communication tools and resources for the public           
  • Learn about their upcoming events             
  • Sign up to their email list to hear about upcoming opportunities, news, events and more!          

Follow ADeN on X: @DeprescribeAU

Australian Deprescribing Network

Council of Australian Therapeutic Advisory Groups (CATAG)

CATAG is a collaborative incorporating all Australian State and Territory Therapeutic or Medicines Advisory Groups. CATAG is an expert and consensus-based collaboration that influences clinical governance so that a quality use of medicines approach is considered in both policy and practice. CATAG is dedicated to optimising medicines use and promoting the safe, effective, equitable and sustainable use of medicines. CATAG facilitates information and knowledge exchange, provides guidance, and advocates for best practices in therapeutic decision-making.

catag.org.au

Australian Deprescribing Network

The European Association of Hospital Pharmacists (EAHP)

The European Association of Hospital Pharmacists (EAHP) is an association of national organisations representing hospital pharmacists at European and international levels.

EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.

www.eahp.eu

Australian Deprescribing Network

The International Pharmaceutical Federation (FIP)

The International Pharmaceutical Federation (FIP) is the global body for pharmacy, pharmaceutical sciences and pharmaceutical education. Through 158 national organisations, allied organisations (including academic institutional members) and individual members, FIP represents over four million pharmacists, pharmaceutical scientists and pharmaceutical educators around the world.

www.fip.org

NAPSA

National Australian Pharmacy Students’ Association (NAPSA)

The National Australian Pharmacy Students’ Association (NAPSA) is the peak representative body for pharmacy students in Australia. We are a not-for-profit organisation that represents the interests of all pharmacy students in the 19 pharmacy schools located around Australia, providing a range of services and supporting our members and local branches. NAPSA works to promote the pharmacy profession to the public through our involvement in policy development and advocacy, helping to shape the future of the profession. We are committed to promoting and providing professional development opportunities for our members, including networking, leadership and advocacy training, and opportunities to participate in national and international events.

napsa.org.au

Australian Deprescribing Network

Royal Australian College of General Practitioners (RACGP)

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

racgp.org.au

Australian Deprescribing Network

Registry of Senior Australians (ROSA)

The Registry of Senior Australians (ROSA) is a national multisectoral integrated data platform designed to monitor and evaluate the health, service use, social welfare, medication use, mortality, and other outcomes of >3.5 million people who received or are receiving aged care services nationally.

rosaresearch.org

Australian Deprescribing Network

Rx for Climate

Rx for Climate is a global network designed to support environmentally sustainable pharmacy practice and to promote pharmacists' role in mitigating the impacts of climate change on human health. This forum enables pharmacy professionals, students, and educators to access high-quality evidence and practice-relevant resources, and encourages collaboration and sharing of ideas. Our goal is to empower pharmacy practitioners to minimize the environmental impacts of healthcare while optimizing patient outcomes.

rxforclimate.org

Pharmacists for the Environment Australia

Pharmacists for the Environment Australia (PEA)

Pharmacists for the Environment Australia (PEA) is committed to advocacy & promotion of sustainable pharmacy practices for better human and planet health.

Connect on Facebook



Resources and publications

Past Campaign References

Key publications

Clinical Resources

Medicines and Sustainability

  • The environmental footprint of health care: a global assessment, Lenzen, Manfred et al. The Lancet Planetary Health, Volume 4, Issue 7, e271 - e279
  • The carbon footprint of Australian health care, Malik, Arunima et al. The Lancet Planetary Health, Volume 2, Issue 1, e27 - e35
  • Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation, Piët, Joost D et al. The Lancet Planetary Health, Volume 8, Issue 10, e715 - e716
  • Wurzel DF, Montgomery BD, Anderson N, Schneider-Futschik EK, George J, Bosnic-Anticevich S, et al. Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement. Respirology. 2024. https://doi.org/10.1111/resp.14852
  • Arunima Malik, Michael Padget, Sarah Carter, Takako Wakiyama, Isis Maitland-Scott, Aditya Vyas, Sinead Boylan, Georgina Mulcahy, Mengyu Li, Manfred Lenzen, Kate Charlesworth, Arne Geschke, Environmental impacts of Australia's largest health system, Resources, Conservation and Recycling,Volume 169,2021,105556,ISSN 09213449, https://www.sciencedirect.com/science/article/abs/pii/S092134492100163



 

In this Section

MedsAware 2024

MedsAware 2024

MedsAware 'Ask because you care' empowers older Australians, Australian living with a disability and their care teams to ask health professionals ‘Could any of these medicines be doing more harm than good?’

MedsAware 2023

MedsAware 2023

In our inaugural year, MedsAware raises awareness around polypharmacy and deprescribing encouraging Australians to check their medicines are current, effective and safe.